seed
Stage
1
Investors
About
NovaResp develops cMAP®, an AI-powered software platform designed to improve adherence to CPAP therapy for patients with obstructive sleep apnea by predicting and preventing apnea episodes through personalized pressure adjustments.
Explore NovaResp's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.